Cargando…
A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer
OBJECTIVE: To evaluate the value of serum complement component 1q (C1q) levels in predicting the efficacy of combined immunotherapy in patients with lung cancer. METHODS: A total of 42 patients with lung cancer who received combined immunotherapy in the cancer center of Renmin Hospital of Wuhan Univ...
Autores principales: | Zhang, Daoming, Li, Yuan, Li, Haoyue, Tang, Tian, Zheng, Yongfa, Guo, Xufeng, Xu, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439965/ https://www.ncbi.nlm.nih.gov/pubmed/34531687 http://dx.doi.org/10.2147/CMAR.S314369 |
Ejemplares similares
-
Macrophages regulate gastrointestinal motility through complement component 1q
por: Pendse, Mihir, et al.
Publicado: (2023) -
Complement component 1q subcomponent binding protein in the brain of the rat
por: Barna, János, et al.
Publicado: (2019) -
MafB is a critical regulator of complement component C1q
por: Tran, Mai Thi Nhu, et al.
Publicado: (2017) -
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
por: Lubbers, Rosalie, et al.
Publicado: (2018) -
Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)